Abstract The gut microbiome is interlinked with renal cell carcinoma (RCC) and its response to systemic treatment. Mounting data suggests that certain elements of the gut microbiome may correlate with…
Highlights • Bacterial infection of the prostate may drive inflammation and cellular plasticity that contributes to the development of prostate cancer. • About 1 mechanism whereby the gut microbiome is…
Highlights • Residual tumor involvement in the trigone and urethra after radical cystectomy is associated with a higher tumor stage, and positive margins. • It was significantly associated with tumor…
Abstract This review assesses the current understanding of the relationship between the human microbiome and BCa. Recognizing how the microbiome affects the tumor microenvironment provides valuable insights into cancer biology,…
Highlights • Since primary testicular lymphoma (PTL) is a rare malignancy, there is no perfect survival prognostic model. • We developed an online prognostic model for predicting the overall survival…
Abstract Objectives To evaluate safety and early and long-term efficacy of CO 2 laser conservative treatments for nonulcerative squamous cell carcinoma (SCC) of the penis. Material and Methods Within our…
Highlights • Lung-only metastases in mCSPC patients showed better outcomes than other visceral metastases. • Bone metastasis volume significantly influenced CRPC-free survival, unlike lung metastases. • Prognoses for patients with…
Highlights • Less than 1% of cancer genome-wide association studies include Hispanic Americans. • Hispanic American men present higher rates of advanced-stage PCa and metastases. • TMPRSS2-ERG (36%) and TMB-High…
Highlights • For image guided prostate bipsy, MRI-microUS and MRI-TRUS fusion biopsy techniques were associated with similar rates of GG upgrade on final pathology after radical prostatectomy. • Both techniques…
Abstract Background Guidelines for prostate cancer treatment in men with limited life expectancy are based on expert opinion. Patient preferences for when to defer treatment based on longevity are unknown….
